ARN8 or HCT116 p53 WT or KO cells were seeded in a 96-well plate at a density of 4000 cells/well in a volume of 100 μl. The cells were incubated as described above for about 24 h prior to treatment. The medium of the assigned wells was replaced with 100 μl of fresh medium containing a 5 μm concentration of the corresponding Tenovins or DMSO control and placed in an IncuCyte S3 system located inside a CO2 incubator. The cell growth was monitored every 2 h for a total of 72 h after an initial 30-min incubation period. The cell confluence percentage was analyzed by IncuCyte S3 2019 Rev 1 software (Essen Biosciences).
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.